Lipoprotein metabolism enzymes

Lipoprotein metabolism enzymes are a broad class of proteins that catalyze the biochemical reactions necessary for the synthesis, transport, and degradation of lipids and lipoproteins in the human body (StatPearls, 2023). This group includes several high-profile therapeutic targets, most notably 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), which is the rate-limiting enzyme in the mevalonate pathway for cholesterol synthesis (PubMed, 2022). Another key enzyme is lipoprotein lipase (LPL), which is essential for the hydrolysis of triglycerides in chylomicrons and very-low-density lipoproteins (VLDL), thereby providing free fatty acids to tissues (NCBI, 2021). Additionally, enzymes such as lecithin-cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) are critical for the maturation of high-density lipoproteins (HDL) and the exchange of lipids between lipoprotein classes (UniProt, 2023). Dysregulation of these enzymatic processes is a central feature of dyslipidemia and metabolic syndrome, contributing significantly to the development of atherosclerosis and cardiovascular disease (PubMed, 2023). Pharmacological interventions targeting these enzymes, such as statins for HMGCR and fibrates for LPL activation, are foundational in clinical practice for reducing cardiovascular risk (StatPearls, 2023). Emerging therapies continue to explore CETP inhibition and LCAT activation to further optimize lipid profiles in high-risk patients (PubMed, 2023).

Other names

Lipid metabolism enzymesLipoprotein-modifying enzymesLipid-regulating enzymes

Competitive inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) to reduce endogenous cholesterol synthesis; activation of peroxisome proliferator-activated receptor alpha (PPAR-alpha) to increase lipoprotein lipase (LPL) expression and triglyceride clearance; inhibition of cholesteryl ester transfer protein (CETP) to increase high-density lipoprotein cholesterol (HDL-C) levels; activation of lecithin-cholesterol acyltransferase (LCAT) to promote the maturation of HDL particles.